THOMAS CHU, MD
Ophthalmology Physician · LOS ANGELES, CA
Individual Active NPI 1760482806
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,203 | 27,296 | $8,025,406 | $2,695,925 | $2,086,643 |
| 2023 | 1,153 | 16,467 | $8,125,959 | $2,783,686 | $2,161,425 |
| 2022 | 1,160 | 12,998 | $6,941,156 | $2,299,943 | $1,773,491 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 14,700 | $34 | $27 |
| 92134 | Imaging of retina | 3,048 | $44 | $33 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 3,024 | $229 | $178 |
| 92014 | Established patient complete exam of visual system | 1,586 | $139 | $98 |
| 67028 | Injection of drug into eye | 1,318 | $124 | $98 |
| 92012 | Established patient problem focused exam of visual system | 1,127 | $99 | $77 |
| J0178 | Injection, aflibercept, 1 mg | 712 | $829 | $652 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 617 | $16 | $10 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 196 | $179 | $125 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 46 | $27 | $18 |
| J9035 | Injection, bevacizumab, 10 mg | 37 | $71 | $52 |
| 92004 | New patient complete exam of visual system | 31 | $164 | $67 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | G68694 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in California
- NPI 1962412643
- NPI 1679758544
- NPI 1992992945
- NPI 1073816070
- NPI 1942369699
- NPI 1295000693
- NPI 1073730081
- NPI 1801390216
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.